
- Volume 0 0
Got RA? Don't Delay!
When it comes to beginning treatment for rheumatoid arthritis, minutes and seconds may not count, but weeks and months surely do.
In a 3-year study at the University Hospital of Vienna and at Lainz Hospital in Austria, researchers found that there is a definite "window of opportunity" for successful treatment.
The study compared patients with very early disease who had waited an average of 3 months before being started on drugs to a group who had waited 20 months to start therapy.
After just 3 months of treatment, patients with early therapy were doing better than those who had waited longer. At the end of the study, 70% of patients in the early-treatment group showed a 20% improvement in disease symptoms. Meanwhile, only 40% of those in the later-treatment group improved.
The researchers concluded that introducing disease-modifying drugs very early "seems highly beneficial in [rheumatoid arthritis] compared with even relatively short delay."
Articles in this issue
over 23 years ago
Olmesartan Medoxomil (CS-866) (Benicar)over 23 years ago
Duration of Breast-Feeding Linked to IQ in Adulthoodover 23 years ago
Sinus Headacheover 23 years ago
Find the Blood Pressure Health Stations Nearest Youover 23 years ago
Quitting Smoling After Age 65 Adds Years To Lifeover 23 years ago
Crab Shells and Cow Cartilageover 23 years ago
Shocking the Immune System to Fight Rheumatoid Arthritisover 23 years ago
Take Blook Pressure in Both Armsover 23 years ago
Fat-Free Doesn't Mean Calorie-Free!over 23 years ago
Heavy Drinker? Even A Short-Term Cut Is GoodNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.